Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in Nuklearmedizin

Retrieve available abstracts of 23 articles:
HTML format
Text format



Single Articles


    September 2018
  1. BOUTER Y, Meller B, Sahlmann CO, Wolf BJ, et al
    Immunohistochemical detection of chemokine receptor 4 expression in chronic osteomyelitis confirms specific uptake in 68Ga-Pentixafor-PET/CT.
    Nuklearmedizin. 2018;57:198-203.
    PubMed     Text format     Abstract available


  2. LAWAL IO, Ankrah AO, Mokoala KMG, Popoola GO, et al
    Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection.
    Nuklearmedizin. 2018;57:190-197.
    PubMed     Text format     Abstract available


  3. BEINDORFF N, Bartelheimer A, Huang K, Lukas M, et al
    Normal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.
    Nuklearmedizin. 2018;57:181-189.
    PubMed     Text format     Abstract available


  4. LIMA GM, Bonfiglioli R, Matti A, Fanti S, et al
    Fluoride PET/CT in Metastatic Benign Pulmonary Calcification.
    Nuklearmedizin. 2018;57:N50-N51.
    PubMed     Text format    


    August 2018
  5. GROSSER OS, Ruf J, Kupitz D, Czuczwara D, et al
    Image Quality Assessment for Low-Dose-CT in Hybrid SPECT/CT Imaging.
    Nuklearmedizin. 2018;57:153-159.
    PubMed     Text format     Abstract available


    June 2018
  6. CHOI BW, Won Kim H, Jeon JC, Kang S, et al
    Nodular fasciitis mimicking malignant soft tissue tumor in an infant, with 18F-FDG PET/CT findings: A case report.
    Nuklearmedizin. 2018;57:N29-N31.
    PubMed     Text format    


  7. STANZEL S, Pernthaler B, Schwarz T, Bjelic-Radisic V, et al
    Diagnostic and prognostic value of additional SPECT/CT in sentinel lymph node mapping in breast cancer patients.
    Nuklearmedizin. 2018;57:92-99.
    PubMed     Text format     Abstract available


  8. KOTZERKE J, Bohmer D, Schlomm T, Maurer T, et al
    [PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection].
    Nuklearmedizin. 2018;57:69-73.
    PubMed     Text format     Abstract available


    April 2018
  9. SCHOEN M, Braun T, Manava P, Ludwigs S, et al
    Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
    Nuklearmedizin. 2018;57:50-55.
    PubMed     Text format     Abstract available


    February 2018
  10. SCHAEFER WM, Knollmann D, Avondo J, Meyer A, et al
    Volume/perfusion ratio from lung SPECT/CT.
    Nuklearmedizin. 2018;57:31-34.
    PubMed     Text format     Abstract available


  11. DRAGER DL, Heuschkel M, Protzel C, Erbersdobler A, et al
    [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
    Nuklearmedizin. 2018;57:26-30.
    PubMed     Text format     Abstract available


  12. BOY C, Poeppel T, Kotzerke J, Krause BJ, et al
    [Somatostatin receptor PET/CT (SSTR-PET/CT)].
    Nuklearmedizin. 2018;57:4-17.
    PubMed     Text format     Abstract available


    July 2017
  13. ZHANG Y, Li B, Shi H, Yu H, et al
    Added value of SPECT/spiral CT versus SPECT or CT alone in diagnosing solitary skeletal lesions.
    Nuklearmedizin. 2017;56.
    PubMed     Text format     Abstract available


    June 2017
  14. LINDNER O, Bengel F, Burchert W, Dorr R, et al
    [Myokard-Perfusions-SPECT. Myocardial perfusion SPECT - Update S1 guideline].
    Nuklearmedizin. 2017;56.
    PubMed     Text format     Abstract available


    May 2017
  15. LEE JW, Park JS, Park KB, Yoo GH, et al
    Prediction of renal cortical defect and scar using neutrophil-to-lymphocyte ratio in children with febrile urinary tract infection.
    Nuklearmedizin. 2017 May 10. doi: 10.3413/Nukmed-0878.
    PubMed     Text format     Abstract available


    April 2017
  16. LUTJE S, Cohnen J, Gomez B, Gruneisen J, et al
    Integrated 68Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancer.
    Nuklearmedizin. 2017 Apr 12. doi: 10.3413/Nukmed-0850.
    PubMed     Text format     Abstract available


    December 2016
  17. ILHAN H, Mustafa M, Bartenstein P, Kuwert T, et al
    Rate of elimination of radioiodine-avid lymph node metastases of differentiated thyroid carcinoma by postsurgical radioiodine ablation. A bicentric study.
    Nuklearmedizin. 2016;55:221-227.
    PubMed     Text format     Abstract available


    September 2016
  18. POPPEL TD, Andreeff M, Becherer A, Bockisch A, et al
    [Therapy of bone metastases with radium-223. German guidelines].
    Nuklearmedizin. 2016;55:177-86.
    PubMed     Text format     Abstract available


    August 2016
  19. LI B, Zhang M, Jin J
    Unusual FDG uptakes of mesenteric brown adipose tissue in a patient with pheochromocytomas.
    Nuklearmedizin. 2016;55:N32-3.
    PubMed     Text format    


  20. SCHUTZE C, Knoop BO, Vehrenkamp I, Rudolf F, et al
    [Constancy check of system linearity for dose calibrators. Effect of molybdenum impurities at high start activities of 99mTc].
    Nuklearmedizin. 2016;55:172-5.
    PubMed     Text format     Abstract available


  21. KIM SJ, Choi JY, Lee JH, Hyun SH, et al
    Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.
    Nuklearmedizin. 2016;55:166-71.
    PubMed     Text format     Abstract available


    June 2016
  22. FENDLER WP, Kratochwil C, Ahmadzadehfar H, Rahbar K, et al
    [177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer].
    Nuklearmedizin. 2016;55:123-8.
    PubMed     Text format     Abstract available


  23. DIETLEIN M, Eschner W, Grunwald F, Lassmann M, et al
    [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
    Nuklearmedizin. 2016;55:77-89.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: